Royce & Associates LP Harmony Biosciences Holdings, Inc. Transaction History

Royce & Associates LP

  • $10.3 Billion
  • Q4 2024

A detailed history of Royce & Associates LP transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Royce & Associates LP holds 81,759 shares of HRMY stock, worth $2.83 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
81,759
Previous 78,703 3.88%
Holding current value
$2.83 Million
Previous $3.14 Million 10.53%
% of portfolio
0.03%
Previous 0.03%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025
BUY
$31.86 - $41.49 $97,364 - $126,793
3,056 Added 3.88%
81,759 $2.81 Million
Q3 2024

Nov 06, 2024
SELL
$30.0 - $39.95 $342,390 - $455,949
-11,413 Reduced 12.66%
78,703 $3.14 Million
Q2 2024

Aug 13, 2024
SELL
$28.81 - $33.01 $233,994 - $268,107
-8,122 Reduced 8.27%
90,116 $2.72 Million
Q1 2024

May 13, 2024
SELL
$29.93 - $35.06 $340,154 - $398,456
-11,365 Reduced 10.37%
98,238 $3.3 Million
Q4 2023

Feb 12, 2024
SELL
$19.2 - $33.78 $3.28 Million - $5.77 Million
-170,746 Reduced 60.9%
109,603 $3.54 Million
Q3 2023

Nov 09, 2023
BUY
$31.89 - $39.03 $1.94 Million - $2.37 Million
60,770 Added 27.68%
280,349 $9.19 Million
Q2 2023

Aug 07, 2023
SELL
$30.5 - $37.4 $3.44 Million - $4.22 Million
-112,750 Reduced 33.93%
219,579 $7.73 Million
Q1 2023

May 04, 2023
BUY
$30.8 - $53.92 $3.14 Million - $5.5 Million
102,059 Added 44.32%
332,329 $10.9 Million
Q4 2022

May 23, 2023
SELL
$45.4 - $60.91 $4.63 Million - $6.22 Million
-102,059 Reduced 30.71%
230,270 $12.7 Million
Q4 2022

Feb 13, 2023
SELL
$45.4 - $60.91 $2.98 Million - $4 Million
-65,740 Reduced 22.21%
230,270 $12.7 Million
Q3 2022

Nov 03, 2022
BUY
$42.06 - $55.45 $1.17 Million - $1.54 Million
27,813 Added 10.37%
296,010 $13.1 Million
Q2 2022

Aug 04, 2022
BUY
$33.54 - $52.15 $415,560 - $646,138
12,390 Added 4.84%
268,197 $13.1 Million
Q1 2022

May 05, 2022
BUY
$33.14 - $51.13 $1.22 Million - $1.88 Million
36,723 Added 16.76%
255,807 $12.4 Million
Q4 2021

Feb 07, 2022
SELL
$34.09 - $43.91 $351,331 - $452,536
-10,306 Reduced 4.49%
219,084 $9.34 Million
Q3 2021

Nov 10, 2021
BUY
$25.68 - $38.61 $2.6 Million - $3.91 Million
101,340 Added 79.14%
229,390 $8.79 Million
Q2 2021

Aug 06, 2021
BUY
$25.96 - $33.44 $3.32 Million - $4.28 Million
128,050 New
128,050 $3.62 Million

Others Institutions Holding HRMY

# of Institutions
255
Shares Held
46.6M
Call Options Held
119K
Put Options Held
50K
View Full List

About Harmony Biosciences Holdings, Inc.

HRMY Quotes by TradingView
  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.04B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Royce & Associates LP Portfolio

Follow Royce & Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email